Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
01/2003
01/09/2003US20030008368 Serine O-acetytransferase
01/09/2003US20030008354 Peptide for use in the diagnosis and treatment of parkinson's, cancer and developmental defects
01/09/2003US20030008353 Nucleotide sequences coding polypeptide for use in the diagnosis and treatment of tumors
01/09/2003US20030008352 Secreted and transmembrane polypeptides and nucleic acids encoding the same
01/09/2003US20030008351 Nucleotide sequences coding polypeptide for use in the treatment of heart defects
01/09/2003US20030008350 14273 receptor, a novel G-protein coupled receptor
01/09/2003US20030008349 Molecular regulatory circuits to achieve sustained activation of genes of interest by a single stress
01/09/2003US20030008345 Expression augmenting sequence elements (EASE) for eukaryotic expression systems
01/09/2003US20030008344 T1R taste receptors and genes encoding same
01/09/2003US20030008340 Metabolic biosensor and uses thereof
01/09/2003US20030008334 Protein for use in the diagnosis, prevention and treatment of cancer
01/09/2003US20030008321 Antibody for use as tool in immunoassay
01/09/2003US20030008297 Secreted and transmembrane polypeptides and nucleic acids encoding the same
01/09/2003US20030008291 Protein for use in diagnosis and treatment of cancer
01/09/2003US20030008288 Detection and treatment of polycystic kidney disease
01/09/2003US20030008284 Polynucleotides related to colon cancer
01/09/2003US20030008279 Cells for use in the diagnosis and treatment of viral diseases
01/09/2003US20030008273 Methods for increasing the survival of neuronal cells
01/09/2003US20030007955 Enclosures housing cell-coated supports for treating tumors
01/09/2003US20030007952 Polypeptides
01/09/2003CA2650762A1 Capsules containing vital cells or tissues
01/09/2003CA2486789A1 Compositions and methods for inferring a response to a statin
01/09/2003CA2452196A1 T cell regulatory genes and methods of use thereof
01/09/2003CA2452082A1 Extracellular messengers
01/09/2003CA2452029A1 A group of .alpha.-amylases and a method for identification and production of .alpha.-amylases
01/09/2003CA2451580A1 Artificial synapse chip interface for electronic prosthetic retina
01/09/2003CA2451317A1 T1r hetero-oligomeric taste receptors and cell lines that express said receptors and use thereof for identification of taste compounds
01/09/2003CA2451236A1 Peptides for use as translocation factors
01/09/2003CA2450710A1 Methods for the simultaneous detection of hcv antigens and hcv antibodies
01/09/2003CA2449105A1 Novel technology for genetic mapping
01/09/2003CA2446580A1 Process and apparatus for utilization of in vivo extracted plasma with tissue engineering devices, bioreactors, artificial organs, and cell therapy applications
01/09/2003CA2429429A1 Method for detecting calpain 3 activity in a biological sample and peptides for implementing said method
01/08/2003WO2002012543A2 Two coloured fluorimetric protease assay
01/08/2003EP1273662A2 Reversible nuclear genetic system for male sterility in transgenic plants
01/08/2003EP1273312A2 Implant for cartilage tissue regeneration
01/08/2003EP1273304A2 Use of interleukin-15
01/08/2003EP1272846A1 Compositions and methods for induction of proteins involved in xenobiotic metabolism
01/08/2003EP1272677A1 Suppressor of hiv replication and transcription
01/08/2003EP1272668A2 Methods, compositions and kits for the detection and monitoring of breast cancer
01/08/2003EP1272663A2 Polymorphisms in the human cyp2b6 gene and their use in diagnostic and therapeutic applications
01/08/2003EP1272656A1 Human serine racemase
01/08/2003EP1272647A1 Multivalent antibodies and uses therefor
01/08/2003EP1272642A2 Coffee mannanase
01/08/2003EP1272641A2 Serine-threonine kinase
01/08/2003EP1272638A2 Drug metabolizing enzymes
01/08/2003EP1272636A2 A gene differentially expressed in breast and bladder cancer and encoded polypeptides
01/08/2003EP1272635A1 Cryptic-like secreted protein
01/08/2003EP1272633A2 Compositions and methods for dendritic cell-based immunotherapy
01/08/2003EP1272630A2 Methods and compositions for rna interference
01/08/2003EP1272629A1 Genetic silencing
01/08/2003EP1272624A1 A process for the production of human interferon alpha from genetically engineered yeast
01/08/2003EP1272621A1 Plant anthocyanidin rutinoside aromatic acyl transferases
01/08/2003EP1272619A2 Human ovarian mesothelial cells and methods of isolation and uses thereof
01/08/2003EP1272618A2 Synchronization of the cytoplasmatic and nuclear maturation of oocytes in vitro
01/08/2003EP1272617A2 Prostate cell lines and their use
01/08/2003EP1272616A2 Human pancreatic epithelial progenitor cells and methods of isolation and use thereof
01/08/2003EP1272615A2 Osteocalcin promoter directed adenovirus replicaton for therapy
01/08/2003EP1272614A1 Differentiation of bone marrow cells into neuronal cells and uses therefor
01/08/2003EP1272612A1 Renilla reniformis green fluorescent protein and mutants thereof
01/08/2003EP1272529A1 Macroporous chitosan beads and preparation method thereof
01/08/2003EP1272527A2 Anti-d monoclonal antibodies
01/08/2003EP1272518A2 Cd20/ige-receptor like molecules and uses thereof
01/08/2003EP1272517A2 Multiprotein-complexes comprising a nmda receptor and uses thereof
01/08/2003EP1272514A1 Dna encoding human vanilloid receptor vr3
01/08/2003EP1272513A2 Neurogenic compositions and methods
01/08/2003EP1272511A2 Molecules associated with human reproduction
01/08/2003EP1272506A1 Human aminoacyl-trna synthetase polypeptides useful for the regulation of angiogenesis
01/08/2003EP1272503A1 DNA MOLECULES ENCODING L-GLUTAMATE-GATED CHLORIDE CHANNELS FROM i RHIPICEPHALUS SANGUINEUS /i
01/08/2003EP1272502A2 Dna molecules and polypeptides of pseudomonas syringae hrp pathogenicity island and their uses
01/08/2003EP1272205A1 Sialoadhesin factor-2 antibodies
01/08/2003EP1272204A2 Soft tissue and bone augmentation and bulking utilizing muscle-derived progenitor cells, compositions and treatments thereof
01/08/2003EP1272203A2 Treatment of disorders by implanting stem cells and/or progeny thereof into gastrointestinal organs
01/08/2003EP1080189A4 Compositions and methods for the synthesis of fatty acids, their derivatives and downstream products
01/08/2003EP1005358B1 Use of a neurturin protein product for preventing and treating hearing loss
01/08/2003EP0996727B1 Gene conferring obese phenotype
01/08/2003EP0974111B1 Apparatus and method for automated protein design
01/08/2003EP0929579B1 Monoclonal antibodies against a human act and serine protease complex
01/08/2003EP0751996B1 Luciferases
01/08/2003EP0728194B1 In situ modification and manipulation of stem cells of the central nervous system
01/08/2003EP0607309B1 The regulation of systemic immune responses utilizing cytokines and antigens
01/08/2003CN1390258A Factor IX/factor IXa antibodies and antibody derivatives
01/08/2003CN1390257A Transfer compounds, the production and the use thereof
01/08/2003CN1390233A Antitumor antibodies, proteins, and uses thereof
01/08/2003CN1390232A Human beta-secretase enzyme, inhibitor, and its composition and use
01/08/2003CN1390141A Nucleic acid-containing complex
01/08/2003CN1390138A Novel use of antibodies as vaccines
01/08/2003CN1389566A Nerve stem cell culture medium and its prepn.
01/08/2003CN1389565A Culture process of human nerve stem cell
01/08/2003CN1389184A Biotechnological body bone tissue rack and its making process and use
01/08/2003CA2415458A1 Two coloured fluorimetric protease assay
01/07/2003US6504082 Ecdysone receptors and methods for their use
01/07/2003US6504007 GDNF receptor
01/07/2003US6503881 Compositions and methods for treating infections using cationic peptides alone or in combination with antibiotics
01/07/2003US6503753 Method for the development of an HIV vaccine
01/07/2003US6503737 Isolated nucleic acids relating to the fkbA gene within the FK-520 polyketide synthase gene cluster
01/07/2003US6503733 Polynucleotides which identify and encode NANCH. The invention also provides genetically engineered expression vectors and host cells comprising the nucleic acid sequences encoding NANCH and a method for producing NANCH. Agonists, antibodies
01/07/2003US6503731 Fibrin microbeads prepared from fibrinogen, thrombin and factor XIII for binding cells
01/07/2003US6503728 A nucleic acid comprising a nucleic acid sequence encoding pantropic hNT3 or hNGF having an alanine residue substituted at a position corresponding to D15 in hNT3 or D16 in hNGF, wherein the alanine substitution imparts trkB-binding such
01/07/2003US6503717 Detecting gene asociated with preferential phenotype; obtain preferential nucleotide sequences, transduce cells, culture cells, recover cell of preferential phenotype, monitor gene expression in recovered cells
01/07/2003US6503513 Diagnostics and therapy of diseases associated with HHV-8 infections